These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2199281)

  • 1. Action profiles of fast onset insulin analogues.
    Heinemann L; Starke AA; Heding L; Jensen I; Berger M
    Diabetologia; 1990 Jun; 33(6):384-6. PubMed ID: 2199281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action profile of the rapid acting insulin analogue: human insulin B28Asp.
    Heinemann L; Heise T; Jorgensen LN; Starke AA
    Diabet Med; 1993 Jul; 10(6):535-9. PubMed ID: 8365089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.
    Kang S; Brange J; Burch A; Vølund A; Owens DR
    Diabetes Care; 1991 Nov; 14(11):1057-65. PubMed ID: 1797487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulin.
    Heinemann L; Chantelau EA; Starke AA
    Diabete Metab; 1992; 18(1):21-4. PubMed ID: 1563532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel insulin formulation with a more rapid onset of action.
    Steiner S; Hompesch M; Pohl R; Simms P; Flacke F; Mohr T; Pfützner A; Heinemann L
    Diabetologia; 2008 Sep; 51(9):1602-6. PubMed ID: 18641968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of monomeric insulin analogues of different receptor affinity.
    Robertson DA; Singh BM; Hale PJ; Jensen I; Nattrass M
    Diabet Med; 1992 Apr; 9(3):240-6. PubMed ID: 1576805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin.
    ter Braak EW; Woodworth JR; Bianchi R; Cerimele B; Erkelens DW; Thijssen JH; Kurtz D
    Diabetes Care; 1996 Dec; 19(12):1437-40. PubMed ID: 8941480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin analogues--not faster than U 40 regular human insulin?
    Chantelau E; Heinemann L
    Diabetes Res Clin Pract; 1993; 21(2-3):201-2. PubMed ID: 7903629
    [No Abstract]   [Full Text] [Related]  

  • 9. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.
    Heinemann L; Klappoth W; Rave K; Hompesch B; Linkeschowa R; Heise T
    Diabetes Care; 2000 Sep; 23(9):1343-7. PubMed ID: 10977030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.
    Mudaliar SR; Lindberg FA; Joyce M; Beerdsen P; Strange P; Lin A; Henry RR
    Diabetes Care; 1999 Sep; 22(9):1501-6. PubMed ID: 10480516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-action profile of inhaled insulin.
    Heinemann L; Traut T; Heise T
    Diabet Med; 1997 Jan; 14(1):63-72. PubMed ID: 9017356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
    Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
    Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the pharmacodynamic profiles of jet-injected regular human insulin versus conventionally administered insulin aspart in healthy volunteers.
    Engwerda EEC; Tack CJ; de Galan BE
    Diabetes Res Clin Pract; 2016 Nov; 121():86-90. PubMed ID: 27662042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
    Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T
    Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes.
    Heinemann L; Nosek L; Flacke F; Albus K; Krasner A; Pichotta P; Heise T; Steiner S
    Diabetes Obes Metab; 2012 Mar; 14(3):222-7. PubMed ID: 21981286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo potency of insulin analogues designed for clinical use.
    Vølund A; Brange J; Drejer K; Jensen I; Markussen J; Ribel U; Sørensen AR; Schlichtkrull J
    Diabet Med; 1991 Nov; 8(9):839-47. PubMed ID: 1663018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of intraperitoneal versus subcutaneous insulin delivery on glucose homeostasis in patients with NIDDM. Veterans Affairs Implantable Insulin Pump Study Group.
    Kelley DE; Henry RR; Edelman SV
    Diabetes Care; 1996 Nov; 19(11):1237-42. PubMed ID: 8908387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.
    Heinemann L; Heise T; Wahl LC; Trautmann ME; Ampudia J; Starke AA; Berger M
    Diabet Med; 1996 Jul; 13(7):625-9. PubMed ID: 8840095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional and sprinkler needle injection of magnesium insulin.
    Colagiuri S; Bryson J; Keating S; Tan L; King J; Eigenmann C; Jørgensen KH
    Diabet Med; 1992; 9(7):616-21. PubMed ID: 1511567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.